Sign up to save your podcasts
Or
Share Understanding GLP-1: The Latest Research from WHOOP with Dr. Greg Grosicki
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Understanding GLP-1: The Latest Research from WHOOP with Dr. Greg Grosicki
Are GLP-1 medications the future of weight loss? On this week’s episode, WHOOP Global Head of Human Performance Principal Scientist, Kristen Holmes, sits down with Dr. Greg Grosicki, WHOOP Senior Research Scientist, to discuss all things GLP-1 and GLP-1 Receptor Agonists (RAs). Dr. Greg Grosicki is a member of the Performance Science team at WHOOP, an accomplished IRONMAN athlete, and holds a PhD in Human Bioenergetics and a Masters Degree in Data Science. Dr. Grosicki’s background focusses on exercise physiology and aims to help people live longer and healthier in order to perform at their peak. Dr. Grosicki recently led a study at WHOOP that looked into the effects of GLP-1 RAs on heart health and responses in health behaviors.
Kristen and Dr. Grosicki discuss Dr. Grosicki’s journey to WHOOP and his research background (1:32), using exercise physiology to help people live longer and healthier (02:52), and how research at WHOOP will help you live better (06:07). Dr. Grosicki dives into the WHOOP GLP-1 study (10:54), GLP-1 medications access (20:48), and what people should expect from a GLP-1RA (23:09). Kristen and Dr. Grosicki break down GLP-1 RAs, their relationships with food addiction (24:30), Hollywood (26:16), and the idea of microdosing drugs like ozempic (27:10). The episode continues, providing an understanding for the importance of studying GLP-1 and using WHOOP as a tool for data collection (28:20), the study’s results (32:56), and identifying research bias (35:55). Kristen and Dr. Grosicki discuss the relationship of GLP-1 and cardiovascular health (39:07), the impact of exercise on cardiovascular health (40:28) and maintaining muscle tissue when using GLP-1RAs (43:42).
Read the study here:
Heart and health behavior responses to GLP-1 receptor agonists: a 12-wk study using wearable technology and causal inference
Support the show
Follow WHOOP:
www.whoop.com
Trial WHOOP for Free
TikTok
YouTube
X
Follow Will Ahmed:
X
Follow Kristen Holmes:
Follow Emily Capodilupo:
View all episodes
By WHOOP
4.7
632632 ratings
Are GLP-1 medications the future of weight loss? On this week’s episode, WHOOP Global Head of Human Performance Principal Scientist, Kristen Holmes, sits down with Dr. Greg Grosicki, WHOOP Senior Research Scientist, to discuss all things GLP-1 and GLP-1 Receptor Agonists (RAs). Dr. Greg Grosicki is a member of the Performance Science team at WHOOP, an accomplished IRONMAN athlete, and holds a PhD in Human Bioenergetics and a Masters Degree in Data Science. Dr. Grosicki’s background focusses on exercise physiology and aims to help people live longer and healthier in order to perform at their peak. Dr. Grosicki recently led a study at WHOOP that looked into the effects of GLP-1 RAs on heart health and responses in health behaviors.
Kristen and Dr. Grosicki discuss Dr. Grosicki’s journey to WHOOP and his research background (1:32), using exercise physiology to help people live longer and healthier (02:52), and how research at WHOOP will help you live better (06:07). Dr. Grosicki dives into the WHOOP GLP-1 study (10:54), GLP-1 medications access (20:48), and what people should expect from a GLP-1RA (23:09). Kristen and Dr. Grosicki break down GLP-1 RAs, their relationships with food addiction (24:30), Hollywood (26:16), and the idea of microdosing drugs like ozempic (27:10). The episode continues, providing an understanding for the importance of studying GLP-1 and using WHOOP as a tool for data collection (28:20), the study’s results (32:56), and identifying research bias (35:55). Kristen and Dr. Grosicki discuss the relationship of GLP-1 and cardiovascular health (39:07), the impact of exercise on cardiovascular health (40:28) and maintaining muscle tissue when using GLP-1RAs (43:42).
Read the study here:
Heart and health behavior responses to GLP-1 receptor agonists: a 12-wk study using wearable technology and causal inference
Support the show
Follow WHOOP:
www.whoop.com
Trial WHOOP for Free
TikTok
YouTube
X
Follow Will Ahmed:
X
Follow Kristen Holmes:
Follow Emily Capodilupo:
More shows like WHOOP Podcast
View all
The Rich Roll Podcast
11,857 Listeners
FoundMyFitness
5,340 Listeners
High Intensity Health with Mike Mutzel, MS
1,229 Listeners
Finding Mastery with Dr. Michael Gervais
1,662 Listeners
The Diary Of A CEO with Steven Bartlett
7,013 Listeners
The Ready State Podcast
500 Listeners
Modern Wisdom
3,766 Listeners
The Proof with Simon Hill
2,603 Listeners
The Peter Attia Drive
8,010 Listeners
The Nick Bare Podcast
5,761 Listeners
Huberman Lab
28,531 Listeners
Longevity by Design
183 Listeners
The Matt Walker Podcast
901 Listeners
The Dr. Gabrielle Lyon Show
1,137 Listeners
Science & Soul with Dr Kristen Holmes
33 Listeners